Full-Time

Manager – Quality Assurance

Confirmed live in the last 24 hours

Neuralink

Neuralink

501-1,000 employees

Develops brain-computer interfaces for medical use

Compensation Overview

$95k - $176k/yr

Mid, Senior

Austin, TX, USA

Category
QA & Testing
Quality Assurance
Required Skills
Risk Management
Google Cloud Platform
Requirements
  • Bachelor’s Degree in a science, engineering, or quality-related discipline, or equivalent experience
  • 3+ years of professional experience in an FDA-regulated environment
  • Demonstrated leadership skills
  • Excellent communication and collaboration skills
  • Strong attention to detail and organizational abilities
Responsibilities
  • Lead risk management activities to identify, assess, and mitigate potential risks to quality and compliance within company operations
  • Collaborate with internal stakeholders to establish and maintain key performance indicators (KPIs) for quality and compliance metrics
  • Manage a team of quality assurance professionals responsible for preclinical and clinical study compliance, and GMP manufacturing compliance
  • Review processes, protocols, reports, and other company activities for regulatory compliance
  • Serve as a subject matter expert for quality-related inquiries and provide guidance to internal teams on quality matters
  • Support the development and maintenance of the company's quality manual, policy, and objectives
  • Conduct risk assessments for new product development projects to ensure quality and compliance considerations are addressed
  • Lead root cause analysis investigations for quality incidents or deviations to identify underlying issues and implement corrective actions
  • Write, review, and approve SOPs to promote adherence to GMP, GCP, and/or GLP processes
  • Implement and maintain a robust internal audit program to regularly assess adherence to quality management system requirements
  • Coordinate, facilitate, and lead internal and external quality audits by regulatory agencies and third-party auditors
Desired Qualifications
  • Expertise in EU MDR, ISO 13485, FDA 21 CFR Part 820, and global quality standards
  • Experience auditing and managing GxP processes

Neuralink develops brain-computer interfaces (BCIs) that enable direct communication between the brain and external devices. Their main product, the N1 Implant, is a small, fully implantable device that allows users to control computers or mobile devices through their brain activity. The implant is powered by a wirelessly charged battery and uses custom chips to process neural signals, which are then sent to the Neuralink Application that translates these signals into commands. What sets Neuralink apart from competitors is its use of a surgical robot that precisely inserts ultra-thin threads into the brain, minimizing damage during the procedure. The company's goal is to restore autonomy to individuals with mobility issues or neurological disorders, while also appealing to those interested in enhancing cognitive abilities.

Company Size

501-1,000

Company Stage

Series E

Total Funding

$1.3B

Headquarters

Fremont, California

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Neuralink raised $650 million in Series E funding to expand patient access.
  • The FDA granted 'breakthrough' status for Neuralink's speech restoration device.
  • Advancements in AI-driven neural signal decoding enhance Neuralink's device performance.

What critics are saying

  • Ethical concerns about brain-machine interfaces could lead to public backlash.
  • Competing technologies from companies like Synchron and Kernel may outpace Neuralink.
  • The complexity and cost of N1 Implant surgeries may limit accessibility.

What makes Neuralink unique

  • Neuralink's N1 Implant is a fully implantable, cosmetically invisible brain-machine interface.
  • The surgical robot developed by Neuralink ensures precise and minimally invasive implantation.
  • Neuralink's technology translates brain activity into computer commands, restoring autonomy to users.

Help us improve and share your feedback! Did you find this helpful?

Benefits

An opportunity to change the world and work with some of the smartest and the most talented experts from different fields.

Growth potential. We rapidly advance team members who have an outsized impact.

Excellent medical, dental, and vision insurance through a PPO plan; parental leave.

Flexible time off + paid holidays.

Equity + 401(k) plan.

Commuter Benefits.

Meals provided.

Growth & Insights and Company News

Headcount

6 month growth

-3%

1 year growth

0%

2 year growth

0%
Tech Gist Africa
Jun 15th, 2025
Neuralink Raises $650M for Brain Implants

Neuralink, Elon Musk's neurotechnology company, raised $650 million in a Series E funding round. The funds will expand patient access, develop new brain implant devices, and enhance clinical trials. Neuralink's technology, tested in patients with severe paralysis, allows control of devices via thoughts. The FDA granted "breakthrough" status for its speech restoration device. Investors include ARK Invest, Sequoia Capital, and others. Neuralink's pre-funding valuation was approximately $9 billion.

Breaking The News
Jun 12th, 2025
Neuralink raises $649M in equity financing

Neuralink Corp., led by CEO Jared Birchall, has raised $649 million in an equity sale, as revealed in an SEC filing. The sale took place on May 30, 2025, with a minimum investment of $12,019 required from outside investors. The company did not disclose its revenue range.

CNBC
Jun 3rd, 2025
5 things to know before the stock market opens Tuesday

Neuralink, Elon Musk's brain tech startup, said it has closed a $650 million funding round led by ARK Invest, Founders Fund, Sequoia Capital, Thrive Capital, Lightspeed Venture Partners and others.

Goo News
Jun 3rd, 2025
Neuralink Raises $650M in Funding Round

Neuralink, led by Elon Musk, raised $650 million in a Series E funding round, with participation from at least 11 investment firms, including Ark Investment Management and Sequoia Capital. The company plans to use the funds to expand patient access and develop next-generation devices that enhance the connection between biological intelligence and AI. Neuralink is valued at $9 billion. Since the last funding round in August 2023, five patients with severe paralysis have used its devices.

ITmedia
Jun 2nd, 2025
Neuralink Raises $650M in Series E

Neuralink, founded by Elon Musk in 2016, announced on June 2 that it raised $650 million in a Series E funding round. Investors included ARK Invest, Founders Fund, Sequoia Capital, and Thrive Capital. The company is conducting clinical trials, including implanting brain chips in five severely paralyzed patients, and has started trials at major neurosurgical institutions. The funding will expand clinical trials and accelerate innovation in future devices connecting biology and AI.